<html><html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Language" content="en-us">
<meta name="GENERATOR" content="Microsoft FrontPage 6.0">
<meta name="ProgId" content="FrontPage.Editor.Document">
<meta http-equiv="Content-Type" content="text/html; charset=windows-1252">
<title>Clinical Trials - CARES Foundation, Inc.</title>
<style>
<!--
h1
{mso-style-parent:"";
margin:0pt; text-indent:0pt;
text-align:left;
font-family:Arial;
font-size:12.0pt;
color:black;
font-weight:bold;
}
-->
</style>
</head>
<BODY >
<TABLE style="BORDER-COLLAPSE: collapse" borderColor=#111111 cellSpacing=0 cellPadding=0 width="74%" border=0>
<TBODY>
<TR>
<TD width="80%" colSpan=2>
<p style="margin-top: 0; margin-bottom: 0"><b><font face="Gill Sans MT" size="2">Fall 2006&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font></b><FONT face="Gill Sans MT" size=2>&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; CARES Foundation, Inc.</B></FONT></TD></TR>
<TR>
<TD width="80%" colSpan=2>
<p style="margin-top: 0; margin-bottom: 0"><IMG height=25 src="http://www.caresfoundation.org/news_letter/blue-line2.gif" width=721 border=0 name="Top"></TD></TR>
<TR>
<TD width="25%">
<p style="margin-top: 0; margin-bottom: 0"><a href="fall06_index.htm">Back to Fall 2006 Index</a></TD>
<TD width="75%">
<P align=right style="margin-top: 0; margin-bottom: 0"><A href="http://www.caresfoundation.org/">Home</A></P></TD></TR>
<TR>
<TD width="80%" colSpan=2>
&nbsp;</TD></TR>

<html>
<head>
<meta http-equiv="Content-Language" content="en-us">
<meta name="GENERATOR" content="Microsoft FrontPage 6.0">
<meta name="ProgId" content="FrontPage.Editor.Document">
<meta http-equiv="Content-Type" content="text/html; charset=windows-1252">
<title>CARES Support Groups</title>
</head>
<BODY >
<TABLE style="BORDER-COLLAPSE: collapse" borderColor=#111111 height=735 cellSpacing=0 cellPadding=0 width="100%" border=0>
<TBODY>
<TR>
<TD width="100%" colSpan=3 height=47><B><FONT face=Enviro size=5>
<P align=center style="margin-top: 0; margin-bottom: 0">Clinical Trials </FONT></B></P></TD>
</TR>
<TR>
<TD width="78%" colSpan=3 height=14>
<P align=center style="margin-top: 0; margin-bottom: 0"></P></TD></TR>
<TR>
<TD width="32%" height=103 align="center" style="border-style: none; border-width: medium; padding-left: 4px; padding-right: 4px; padding-top: 1px; padding-bottom: 1px" valign="top">
<p align="center" style="margin-top: 0; margin-bottom: 0"><b><font size="6">CAH 
Steroid Study at Riley Hospital for Children</font></b><br>
<b>Indianapolis, IN</b></p>
<p align="left" style="margin-top: 0; margin-bottom: 0"><br>
Everyone who has CAH is treated with a type of medication known as a �glucocorticoid.� 
There are several different glucocorticoids available, including hydrocortisone 
(Cortef), prednisone and dexamethasone. Traditionally, many physicians treat 
children with CAH with hydrocortisone, which is a short-acting glucocorticoid 
that is usually given three times a day. Longer-acting glucocorticoids, such as 
prednisone or dexamethasone, are not as commonly used because of potential 
concerns related to growth. Little is known about the effects on growth, the 
pituitary gland, or CAH control of these different types of glucocorticoids. 
Improved understanding of the effects of hydrocortisone, prednisone, and 
dexamethasone in children with CAH would lead to better treatment options, 
including the potential of more simplified therapy with only once or twice daily 
dosing.<br>
&nbsp;</p>
<p align="left" style="margin-top: 0; margin-bottom: 0">Our goal is to compare 
different glucocorticoids in children with CAH in order to optimize growth and 
control of CAH so as to avoid the consequences of over-treatment and 
under-treatment. </p>
<p align="left" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p align="left" style="margin-top: 0; margin-bottom: 0">We are recruiting 
children who have classic CAH, are not yet in puberty, and are between the ages 
of 5 and 12 years old. Children will be enrolled at the General Clinical 
Research Center (GCRC) at Indiana University School of Medicine affiliated with 
Riley Hospital for Children in Indianapolis, IN. The study lasts for 18 weeks, 
but requires only 4 visits to Indianapolis. Three of these visits will consist 
of an overnight stay. Each participant will randomly be on a 6-week course of 
each glucocorticoid (hydrocortisone, prednisone, or dexamethasone). </p>
<p align="left" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p align="left" style="margin-top: 0; margin-bottom: 0">All overnight stays, 
including labs, medications, and participation compensation, will be paid for by 
the study. If one is traveling a long distance, arrangements can be made to 
spend the night at the GCRC the night prior to an overnight stay at no cost. </p>
<p align="left" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p align="left" style="margin-top: 0; margin-bottom: 0">If you are interested in 
learning more about our study, please contact either Dr. Erica Eugster at (317) 
274-3889, or Dr. Todd Nebesio at (317) 274- 3889 or by e-mail (<a href="mailto:tdnebesi@iupui.edu?subject=CAH Steroid Study">tdnebesi@iupui.edu</a>).</TD>
<TD width="34%" height=107 style="border-style: solid; border-width: 1px; padding-left: 5px; padding-right: 5px" valign="top">
<p align="center"><b><font size="6">CAH Study at the University of North 
Carolina</font></b><br>
<b>Chapel Hill</b></p>
<p align="left"><b><i>Karen Jane Loechner, M.D./Ph.D.</i></b></p>
<p align="left">We are recruiting children with CAH who are 4-12 years old (bone 
age &lt;14 years), are still growing, and have not yet started puberty. Children 
will be enrolled in the study at the General Clinical Research Center at the 
University of North Carolina, Chapel Hill.</p>
<p align="left">Although cortisol replacement (hydrocortisone, prednisone, or 
dexamethasone, for example) and Florinef have virtually eliminated mortality, 
there are at least two reasons for continuing to try to perfect our treatment 
regimens: (1) the linear growth of children is suboptimal and the end result is 
an adult who is too short, and (2) overtreatment with glucocorticoids in 
children may increase risk of osteoporosis in later years. </p>
<p align="left">Based on studies of the regulation of release of ACTH (that, in 
turn, drives the production of hormones from the adrenal cortex), we have found 
that we can decrease the amount of ACTH using calcium channel blockers 
(medications typically used to treat high blood pressure, such as amlodipine). 
Amlodipine has been shown to be safe even in infants treated for a variety of 
medical reasons. </p>
<p align="left">Our hypothesis is that addition of amlodipine will allow us to 
decrease the amount of glucocorticoid medication that your child is currently 
taking to control his/her CAH. Such a decrease should translate into better 
growth and bone strength. This new medication would be added to your child�s 
current CAH treatment program and evaluated in a double-blind/placebo-controlled 
crossover study. </p>
<p align="left">For more information, please contact Dr. Karen Loechner at (919) 
216-5946 (pager) or (919) 966-4435 ext. 224 (voice mail); fax (919) 966-2423; 
Roxanne Schock, CDE, Clinical Coordinator at (919) 966-0428 (voice mail). All 
visits, including laboratory testing, research medication, and parking will be 
paid for by this protocol. Limited �off-site� testing at your local care 
provider may be available subject to IRB approval. Travel funds available 
(please inquire for details).</TD>
<td style="padding: 5px" valign="top">
<p align="center"><b><font size="6">CAH</font><font size="6"> Volunteers Needed
for Natural History Study</font></b><font size="5"> </font></p>
<p align="center" style="margin-top: 0; margin-bottom: 0"><i>Principal Investigator: Dr. Deborah Merke, M.D.</i></p>
<p align="center" style="margin-top: 0; margin-bottom: 0"><i>Pediatric Endocrinologist and Chief of Pediatric</i></p>
<p align="center" style="margin-top: 0; margin-bottom: 0"><i>Services at the National Institutes of Health</i></p>
<p align="center" style="margin-top: 0; margin-bottom: 0"><i>Clinical
Center, Bethesda, Maryland </i></p>
<p align="center" style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p style="margin-top: 0; margin-bottom: 0">We are currently recruiting patients of all ages with CAH (both classic and nonclassic) for a natural history study at the National Institutes of Health (NIH) in Bethesda, Maryland. By studying the natural history of CAH in a large population of patients, we hope to define new aspects of the disease. This will allow us to develop new management and treatment approaches. Participants will be seen as outpatients at the NIH Clinical Center in Bethesda, Maryland and may be seen once, twice, or for ongoing care. Patients seen for a limited number of visits will have a full report sent to their private physician. All testing is free of charge and will include:
</p>
<ul>
	<li>
	<p style="margin-top: 0; margin-bottom: 12px">Genotyping (patients with 21- Hydroxylase deficiency only)
	</li>
	<li>
	<p style="margin-top: 0; margin-bottom: 12px">Hormonal evaluation including evaluation for insulin resistance
	</li>
	<li>
	<p style="margin-top: 0; margin-bottom: 12px">Psychological and cognitive testing
	</li>
	<li>
	<p style="margin-top: 0; margin-bottom: 12px">Bone age (growing children) and ultrasound
	</li>
</ul>
<p style="margin-top: 0; margin-bottom: 0">For more information or to volunteer, please contact Carol VanRyzin at the NIH at (301) 451-0399. 


</td>
</TR>
<TR>
<TD width="32%" height=26 style="border-right-style: none; border-right-width: medium; border-top-style: none; border-top-width: medium">
&nbsp;</TD>
<TD width="35%" height=27 style="border-style: none; border-width: medium">
&nbsp;</TD>
<TD width="33%" height=26 style="border-left-style: none; border-left-width: medium">&nbsp;</TD>
</TR>
<TR>
<TD width="100%" height=26 style="border-top-style: none; border-top-width: medium" colspan="3" bgcolor="#C0C0C0">
<p style="margin-top: 0; margin-bottom: 0" align="center"><i>The studies 
advertised on these pages have appeared in previous editions of the CARES 
newsletter. We update the clinical trials section of the newsletter and website 
as studies become available. For an up-to-date list, visit
<a href="http://www.caresfoundation.org/clinical_trials.html">
http://www.caresfoundation.org/clinical_trials.html</a>. </i></TD>
</TR>
<TR>
<TD width="32%" height=26 style="border-top-style: none; border-top-width: medium">
&nbsp;</TD>
<TD width="35%" height=27 style="border-top-style: none; border-top-width: medium">
&nbsp;</TD>
<TD width="33%" height=26>
&nbsp;</TD>
</TR>
<TR>
<TD width="100%" height=26 style="border-style:dashed; border-width:1px; padding:5px; " colspan="3">
<p align="center"><b><font size="5">Fund Research While You Shop!!!</font></b><br>
Shop Online at <a href="http://www.iGive.com">iGive.com</a> and Help Us Find a 
Cure</p>
<p align="center">CARES Foundation, Inc. is a registered member of iGive. At the 
mall at <a href="http://www.igive.com">www.igive.com</a> you can shop over 600 
stores and help CARES at the same time. There is no cost or obligation to join, 
and a percentage of your purchase is donated to CARES. To Designate CARES as 
your charity of choice, search the keywords: CARES, CAH or congenital adrenal 
hyperplasia. </p>
<p align="center">Since 2005, CARES has awarded over $150,000 for research. 
Please help us keep it up!<br>
<b><font size="4">Shop, Shop, Shop!</font></b></TD>
</TR>
<TR>
<TD width="32%" height=26 style="border-top-style: none; border-top-width: medium">
&nbsp;</TD>
<TD width="35%" height=27 style="border-top-style: none; border-top-width: medium">
&nbsp;</TD>
<TD width="33%" height=26>
&nbsp;</TD>
</TR>
<TR>
<TD width="32%" height=26 style="border-top-style: none; border-top-width: medium">
<P align=center style="margin-top: 0; margin-bottom: 0"><A href="fall06_index.htm">Back to Fall 2006 Index</A></P></TD>
<TD width="35%" height=27 style="border-top-style: none; border-top-width: medium">
<P align=center style="margin-top: 0; margin-bottom: 0"><A href="#Top">Top</A>&nbsp;&nbsp;&nbsp;&nbsp; </P></TD>
<TD width="33%" height=26>
<p style="margin-top: 0; margin-bottom: 0" align="right"><A href="http://www.caresfoundation.org/">Home</A></TD>
</TR>
<TR>
<TD width="67%" colSpan=2 height=19>
<P align=center style="margin-top: 0; margin-bottom: 0"><IMG height=13 src="http://www.caresfoundation.org/news_letter/red-line3.gif" width=613 align=left border=0></P></TD>
<TD width="33%" height=19>
<p style="margin-top: 0; margin-bottom: 0"></TD></TR>
<TR>
<TD width="67%" colSpan=2 height=19>
<p style="margin-top: 0; margin-bottom: 0">
<FONT size=2>� 2006 CARES Foundation, Inc. All rights reserved. Republication or redistribution of CARES content, including by framing or similar means, is prohibited without the prior written consent of CARES.</FONT></TD>
<TD width="33%" height=19>
<p style="margin-top: 0; margin-bottom: 0"></TD></TR></TR></TBODY></TABLE></BODY>
</html>






<p style="margin-top: 0; margin-bottom: 0">






<TR>
<TD width="28%" height=20>
&nbsp;</TD></TD></TR></TR></TBODY></TABLE></p>

</BODY>
</html>
